214 related articles for article (PubMed ID: 22814619)
1. CITED2 functions as a molecular switch of cytokine-induced proliferation and quiescence.
Chou YT; Hsieh CH; Chiou SH; Hsu CF; Kao YR; Lee CC; Chung CH; Wang YH; Hsu HS; Pang ST; Shieh YS; Wu CW
Cell Death Differ; 2012 Dec; 19(12):2015-28. PubMed ID: 22814619
[TBL] [Abstract][Full Text] [Related]
2. Cited2 modulates TGF-beta-mediated upregulation of MMP9.
Chou YT; Wang H; Chen Y; Danielpour D; Yang YC
Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037
[TBL] [Abstract][Full Text] [Related]
3. Post-transcriptional control of Cited2 by transforming growth factor beta. Regulation via Smads and Cited2 coding region.
Chou YT; Yang YC
J Biol Chem; 2006 Jul; 281(27):18451-62. PubMed ID: 16675452
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of CITED2 contributes to TGFβ-mediated senescence of tendon-derived stem cells.
Hu C; Zhang Y; Tang K; Luo Y; Liu Y; Chen W
Cell Tissue Res; 2017 Apr; 368(1):93-104. PubMed ID: 28084522
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-β-induced expression of VEGFA.
Jayaraman S; Doucet M; Kominsky SL
Oncotarget; 2017 Jan; 8(4):6169-6178. PubMed ID: 28008154
[TBL] [Abstract][Full Text] [Related]
6. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest.
Claassen GF; Hann SR
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9498-503. PubMed ID: 10920185
[TBL] [Abstract][Full Text] [Related]
7. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth.
Cheung KF; Zhao J; Hao Y; Li X; Lowe AW; Cheng AS; Sung JJ; Yu J
Cancer; 2013 Mar; 119(6):1217-26. PubMed ID: 23212831
[TBL] [Abstract][Full Text] [Related]
8. CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.
Korthuis PM; Berger G; Bakker B; Rozenveld-Geugien M; Jaques J; de Haan G; Schuringa JJ; Vellenga E; Schepers H
Leukemia; 2015 Mar; 29(3):625-35. PubMed ID: 25184385
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Cbp/P300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 inhibits cell division and increases apoptosis in gastric cancer.
Tang Z; He G; Xu J; Zhongfu L
J Surg Res; 2017 May; 211():1-7. PubMed ID: 28501104
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic STRAP functions as a novel negative regulator of E-cadherin and p21(Cip1) by modulating the transcription factor Sp1.
Jin L; Datta PK
Cell Cycle; 2014; 13(24):3909-20. PubMed ID: 25483064
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta induces growth arrest in Burkitt lymphoma cells via transcriptional repression of E2F-1.
Spender LC; Inman GJ
J Biol Chem; 2009 Jan; 284(3):1435-42. PubMed ID: 19022773
[TBL] [Abstract][Full Text] [Related]
13. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).
Pardali K; Kowanetz M; Heldin CH; Moustakas A
J Cell Physiol; 2005 Jul; 204(1):260-72. PubMed ID: 15690394
[TBL] [Abstract][Full Text] [Related]
14. Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
Santoni-Rugiu E; Jensen MR; Factor VM; Thorgeirsson SS
Am J Pathol; 1999 Jun; 154(6):1693-700. PubMed ID: 10362794
[TBL] [Abstract][Full Text] [Related]
15. The Effects of miR-20a on p21: Two Mechanisms Blocking Growth Arrest in TGF-β-Responsive Colon Carcinoma.
Sokolova V; Fiorino A; Zoni E; Crippa E; Reid JF; Gariboldi M; Pierotti MA
J Cell Physiol; 2015 Dec; 230(12):3105-14. PubMed ID: 26012475
[TBL] [Abstract][Full Text] [Related]
16. Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2.
Regel I; Merkl L; Friedrich T; Burgermeister E; Zimmermann W; Einwächter H; Herrmann K; Langer R; Röcken C; Hofheinz R; Schmid R; Ebert MP
Gastroenterology; 2012 Jul; 143(1):99-109.e10. PubMed ID: 22465428
[TBL] [Abstract][Full Text] [Related]
17. CITED2 modulates estrogen receptor transcriptional activity in breast cancer cells.
Lau WM; Doucet M; Huang D; Weber KL; Kominsky SL
Biochem Biophys Res Commun; 2013 Jul; 437(2):261-6. PubMed ID: 23811274
[TBL] [Abstract][Full Text] [Related]
18. CITED2 links hormonal signaling to PGC-1α acetylation in the regulation of gluconeogenesis.
Sakai M; Matsumoto M; Tujimura T; Yongheng C; Noguchi T; Inagaki K; Inoue H; Hosooka T; Takazawa K; Kido Y; Yasuda K; Hiramatsu R; Matsuki Y; Kasuga M
Nat Med; 2012 Mar; 18(4):612-7. PubMed ID: 22426420
[TBL] [Abstract][Full Text] [Related]
19. Sequential activation of NFAT and c-Myc transcription factors mediates the TGF-beta switch from a suppressor to a promoter of cancer cell proliferation.
Singh G; Singh SK; König A; Reutlinger K; Nye MD; Adhikary T; Eilers M; Gress TM; Fernandez-Zapico ME; Ellenrieder V
J Biol Chem; 2010 Aug; 285(35):27241-27250. PubMed ID: 20516082
[TBL] [Abstract][Full Text] [Related]
20. A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion.
Bai L; Merchant JL
FEBS Lett; 2007 Dec; 581(30):5904-10. PubMed ID: 18054336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
